| 0 |
MYELODYSPLASTIC SYNDROME WITH MULTILINEAGE DYSPLASIA |
13 |
0.2549 |
| 1 |
IVTH NERVE PARALYSIS |
42 |
0.1772 |
| 2 |
PHALANGEAL HYPOPLASIA |
12 |
0.1690 |
| 3 |
TRANSPLANT ABSCESS |
6 |
0.1304 |
| 4 |
ENCEPHALITIS PROTOZOAL |
7 |
0.1250 |
| 5 |
HAEMOPHILUS BACTERAEMIA |
6 |
0.1224 |
| 6 |
CUTANEOUS MUCORMYCOSIS |
21 |
0.1141 |
| 7 |
MENINGOENCEPHALITIS AMOEBIC |
6 |
0.1034 |
| 8 |
CUTANEOUS MALACOPLAKIA |
5 |
0.0980 |
| 9 |
ACANTHAMOEBA INFECTION |
17 |
0.0904 |
| 10 |
HEPATIC AMOEBIASIS |
6 |
0.0896 |
| 11 |
CAMPYLOBACTER TEST POSITIVE |
6 |
0.0789 |
| 12 |
CUTANEOUS NOCARDIOSIS |
9 |
0.0692 |
| 13 |
VOCAL CORD OPERATION |
6 |
0.0638 |
| 14 |
MALACOPLAKIA |
28 |
0.0611 |
| 15 |
DISSEMINATED TOXOPLASMOSIS |
7 |
0.0583 |
| 16 |
PULMONARY NOCARDIOSIS |
47 |
0.0570 |
| 17 |
SPONTANEOUS BACTERIAL PERITONITIS |
12 |
0.0492 |
| 18 |
TOTAL LUNG CAPACITY INCREASED |
13 |
0.0478 |
| 19 |
SCROTAL ULCER |
11 |
0.0421 |
| 20 |
SUSPECTED DRUG-INDUCED LIVER INJURY |
8 |
0.0400 |
| 21 |
GASTROINTESTINAL TRACT MUCOSAL PIGMENTATION |
10 |
0.0368 |
| 22 |
NOCARDIOSIS |
94 |
0.0367 |
| 23 |
DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION |
8 |
0.0362 |
| 24 |
CEREBELLAR STROKE |
14 |
0.0358 |
| 25 |
CHEST WALL ABSCESS |
7 |
0.0354 |
| 26 |
MORGANELLA INFECTION |
10 |
0.0341 |
| 27 |
PENILE ULCERATION |
11 |
0.0336 |
| 28 |
DEVICE RELATED BACTERAEMIA |
10 |
0.0323 |
| 29 |
ACUTE PULMONARY HISTOPLASMOSIS |
5 |
0.0314 |
| 30 |
BURKHOLDERIA CEPACIA COMPLEX INFECTION |
8 |
0.0280 |
| 31 |
LEISHMANIASIS |
8 |
0.0276 |
| 32 |
IGA NEPHROPATHY |
45 |
0.0271 |
| 33 |
ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME |
14 |
0.0268 |
| 34 |
CONGENITAL FOOT MALFORMATION |
12 |
0.0264 |
| 35 |
CONGENITAL APLASIA |
8 |
0.0257 |
| 36 |
PNEUMOCYSTIS JIROVECII INFECTION |
25 |
0.0209 |
| 37 |
FUNGAL PHARYNGITIS |
5 |
0.0199 |
| 38 |
XANTHOPSIA |
7 |
0.0190 |
| 39 |
ENTEROCOCCAL BACTERAEMIA |
20 |
0.0189 |
| 40 |
HAEMOSIDEROSIS |
5 |
0.0187 |
| 41 |
TOXOPLASMOSIS |
20 |
0.0185 |
| 42 |
CEREBRAL TOXOPLASMOSIS |
17 |
0.0182 |
| 43 |
PROTEUS INFECTION |
13 |
0.0181 |
| 44 |
HUMAN HERPESVIRUS 8 INFECTION |
11 |
0.0181 |
| 45 |
ANAEMIA MEGALOBLASTIC |
8 |
0.0179 |
| 46 |
DISSEMINATED MUCORMYCOSIS |
7 |
0.0178 |
| 47 |
MONOCLONAL IMMUNOGLOBULIN INCREASED |
5 |
0.0175 |
| 48 |
ARTERIOVENOUS FISTULA THROMBOSIS |
6 |
0.0173 |
| 49 |
FUSARIUM INFECTION |
12 |
0.0171 |
| 50 |
WOUND INFECTION BACTERIAL |
7 |
0.0169 |
| 51 |
CHYLOTHORAX |
12 |
0.0166 |
| 52 |
CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER |
6 |
0.0165 |
| 53 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
155 |
0.0154 |
| 54 |
VASOGENIC CEREBRAL OEDEMA |
11 |
0.0153 |
| 55 |
LUNG TRANSPLANT REJECTION |
10 |
0.0152 |
| 56 |
GRAFT VERSUS HOST DISEASE IN LUNG |
7 |
0.0146 |
| 57 |
EVANS SYNDROME |
7 |
0.0142 |
| 58 |
CEREBRAL MASS EFFECT |
5 |
0.0138 |
| 59 |
SYPHILIS |
10 |
0.0138 |
| 60 |
MIXED LIVER INJURY |
41 |
0.0136 |
| 61 |
GENERALISED BULLOUS FIXED DRUG ERUPTION |
5 |
0.0134 |
| 62 |
DISSEMINATED CRYPTOCOCCOSIS |
10 |
0.0132 |
| 63 |
ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION |
12 |
0.0130 |
| 64 |
JARISCH-HERXHEIMER REACTION |
9 |
0.0126 |
| 65 |
ANAL ULCER |
10 |
0.0122 |
| 66 |
VULVAL DISORDER |
8 |
0.0121 |
| 67 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
60 |
0.0120 |
| 68 |
MARROW HYPERPLASIA |
8 |
0.0117 |
| 69 |
IMMUNE RECONSTITUTION SYNDROME |
15 |
0.0116 |
| 70 |
ACQUIRED IMMUNODEFICIENCY SYNDROME |
6 |
0.0116 |
| 71 |
MUCORMYCOSIS |
30 |
0.0115 |
| 72 |
PULMONARY MUCORMYCOSIS |
6 |
0.0114 |
| 73 |
DELAYED GRAFT FUNCTION |
8 |
0.0113 |
| 74 |
MYCOBACTERIAL INFECTION |
19 |
0.0110 |
| 75 |
GRAFT VERSUS HOST DISEASE |
79 |
0.0110 |
| 76 |
ENTEROCOCCAL INFECTION |
53 |
0.0110 |
| 77 |
SYSTEMIC CANDIDA |
25 |
0.0099 |
| 78 |
METHAEMOGLOBINAEMIA |
23 |
0.0099 |
| 79 |
ENTEROCOCCAL SEPSIS |
8 |
0.0099 |
| 80 |
MENINGITIS LISTERIA |
5 |
0.0098 |
| 81 |
GENE MUTATION |
19 |
0.0096 |
| 82 |
CYTOMEGALOVIRUS TEST POSITIVE |
17 |
0.0095 |
| 83 |
THROMBOTIC MICROANGIOPATHY |
90 |
0.0092 |
| 84 |
INFECTIOUS PLEURAL EFFUSION |
14 |
0.0092 |
| 85 |
LICHENOID KERATOSIS |
21 |
0.0092 |
| 86 |
PNEUMONIA FUNGAL |
36 |
0.0091 |
| 87 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
54 |
0.0091 |
| 88 |
STAPHYLOCOCCAL SKIN INFECTION |
11 |
0.0089 |
| 89 |
ENTEROBACTER INFECTION |
15 |
0.0089 |
| 90 |
CYTOMEGALOVIRUS CHORIORETINITIS |
17 |
0.0087 |
| 91 |
HEPATIC CYTOLYSIS |
111 |
0.0087 |
| 92 |
PARAINFLUENZAE VIRUS INFECTION |
13 |
0.0085 |
| 93 |
KLEBSIELLA BACTERAEMIA |
8 |
0.0084 |
| 94 |
DERMO-HYPODERMITIS |
5 |
0.0084 |
| 95 |
KLEBSIELLA INFECTION |
41 |
0.0081 |
| 96 |
VOCAL CORD PARALYSIS |
14 |
0.0078 |
| 97 |
KLEBSIELLA TEST POSITIVE |
5 |
0.0077 |
| 98 |
CYTOMEGALOVIRUS VIRAEMIA |
34 |
0.0076 |
| 99 |
PNEUMOCYSTIS JIROVECI PNEUMONIA |
17 |
0.0076 |
| 100 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
7 |
0.0076 |
| 101 |
GASTROINTESTINAL INJURY |
20 |
0.0074 |
| 102 |
STAPHYLOCOCCAL BACTERAEMIA |
32 |
0.0074 |
| 103 |
GRAFT VERSUS HOST DISEASE IN SKIN |
16 |
0.0073 |
| 104 |
VIRAEMIA |
10 |
0.0072 |
| 105 |
HYPOMANIA |
26 |
0.0071 |
| 106 |
BONE MARROW TRANSPLANT |
13 |
0.0068 |
| 107 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
51 |
0.0068 |
| 108 |
HISTOPLASMOSIS |
12 |
0.0068 |
| 109 |
GRANULOMATOSIS WITH POLYANGIITIS |
8 |
0.0066 |
| 110 |
BICYTOPENIA |
13 |
0.0066 |
| 111 |
FEBRILE BONE MARROW APLASIA |
28 |
0.0066 |
| 112 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
14 |
0.0066 |
| 113 |
ASPERGILLUS INFECTION |
43 |
0.0065 |
| 114 |
PNEUMONIA KLEBSIELLA |
12 |
0.0065 |
| 115 |
URINARY TRACT INFECTION ENTEROCOCCAL |
6 |
0.0064 |
| 116 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
17 |
0.0063 |
| 117 |
GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE |
7 |
0.0062 |
| 118 |
CYTOKINE RELEASE SYNDROME |
125 |
0.0062 |
| 119 |
PNEUMONIA CYTOMEGALOVIRAL |
12 |
0.0062 |
| 120 |
DEMYELINATING POLYNEUROPATHY |
6 |
0.0058 |
| 121 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
19 |
0.0057 |
| 122 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
8 |
0.0057 |
| 123 |
ANAEMIA MACROCYTIC |
12 |
0.0056 |
| 124 |
ESCHERICHIA BACTERAEMIA |
13 |
0.0055 |
| 125 |
HEART TRANSPLANT |
5 |
0.0055 |
| 126 |
PULMONARY SEPSIS |
8 |
0.0055 |
| 127 |
LISTERIOSIS |
6 |
0.0054 |
| 128 |
LYME DISEASE |
18 |
0.0054 |
| 129 |
JAUNDICE CHOLESTATIC |
19 |
0.0054 |
| 130 |
BLOOD PRESSURE SYSTOLIC ABNORMAL |
13 |
0.0053 |
| 131 |
LUNG ABSCESS |
11 |
0.0052 |
| 132 |
AGRANULOCYTOSIS |
97 |
0.0052 |
| 133 |
VASCULAR PSEUDOANEURYSM |
9 |
0.0052 |
| 134 |
BRONCHOPULMONARY ASPERGILLOSIS |
40 |
0.0052 |
| 135 |
BRAIN ABSCESS |
13 |
0.0051 |
| 136 |
IMMUNE-MEDIATED HEPATIC DISORDER |
10 |
0.0051 |
| 137 |
HISTOPLASMOSIS DISSEMINATED |
8 |
0.0050 |
| 138 |
PNEUMOMEDIASTINUM |
9 |
0.0050 |
| 139 |
LUNG OPACITY |
13 |
0.0049 |
| 140 |
ORAL MUCOSA EROSION |
6 |
0.0049 |
| 141 |
STERNAL FRACTURE |
6 |
0.0049 |
| 142 |
CORONAVIRUS TEST POSITIVE |
5 |
0.0049 |
| 143 |
ADENOVIRUS INFECTION |
14 |
0.0048 |
| 144 |
HEART TRANSPLANT REJECTION |
5 |
0.0048 |
| 145 |
CYTOPENIA |
58 |
0.0047 |
| 146 |
LEUKAEMIA RECURRENT |
8 |
0.0047 |
| 147 |
RASH MORBILLIFORM |
13 |
0.0047 |
| 148 |
STEROID DIABETES |
7 |
0.0047 |
| 149 |
ORGANISING PNEUMONIA |
23 |
0.0046 |
| 150 |
BACTERAEMIA |
55 |
0.0046 |
| 151 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
20 |
0.0045 |
| 152 |
FUNGAEMIA |
7 |
0.0044 |
| 153 |
INFECTION REACTIVATION |
5 |
0.0044 |
| 154 |
CENTRAL NERVOUS SYSTEM LYMPHOMA |
6 |
0.0044 |
| 155 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
12 |
0.0043 |
| 156 |
DYSLEXIA |
5 |
0.0043 |
| 157 |
TOXIC EPIDERMAL NECROLYSIS |
65 |
0.0043 |
| 158 |
ESCHERICHIA INFECTION |
35 |
0.0043 |
| 159 |
OPTIC NEUROPATHY |
9 |
0.0042 |
| 160 |
ENCEPHALOPATHY |
104 |
0.0042 |
| 161 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
9 |
0.0042 |
| 162 |
VARICELLA |
10 |
0.0042 |
| 163 |
HYPERURICAEMIA |
17 |
0.0041 |
| 164 |
TONGUE COATED |
7 |
0.0041 |
| 165 |
PNEUMONIA STAPHYLOCOCCAL |
8 |
0.0041 |
| 166 |
HYPERBILIRUBINAEMIA |
42 |
0.0041 |
| 167 |
PNEUMONIA PNEUMOCOCCAL |
6 |
0.0040 |
| 168 |
DIFFUSE LARGE B-CELL LYMPHOMA |
31 |
0.0040 |
| 169 |
OESOPHAGEAL CANDIDIASIS |
16 |
0.0040 |
| 170 |
SPLENIC INFARCTION |
7 |
0.0040 |
| 171 |
PERSECUTORY DELUSION |
10 |
0.0040 |
| 172 |
MENINGITIS CRYPTOCOCCAL |
7 |
0.0040 |
| 173 |
FANCONI SYNDROME ACQUIRED |
7 |
0.0040 |
| 174 |
LUNG TRANSPLANT |
14 |
0.0040 |
| 175 |
IMMUNE-MEDIATED HEPATITIS |
8 |
0.0039 |
| 176 |
CYTOMEGALOVIRUS INFECTION |
65 |
0.0039 |
| 177 |
CALCULUS URINARY |
6 |
0.0039 |
| 178 |
MYELITIS |
6 |
0.0039 |
| 179 |
PNEUMONIA BACTERIAL |
35 |
0.0038 |
| 180 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
33 |
0.0038 |
| 181 |
MYOPIA |
9 |
0.0038 |
| 182 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
29 |
0.0037 |
| 183 |
FEBRILE NEUTROPENIA |
247 |
0.0037 |
| 184 |
PANCYTOPENIA |
208 |
0.0037 |
| 185 |
BRONCHIECTASIS |
25 |
0.0037 |
| 186 |
CRYPTOCOCCOSIS |
6 |
0.0037 |
| 187 |
EPSTEIN-BARR VIRUS INFECTION |
23 |
0.0037 |
| 188 |
VACCINATION FAILURE |
6 |
0.0036 |
| 189 |
RHINOVIRUS INFECTION |
14 |
0.0036 |
| 190 |
RHINITIS ALLERGIC |
16 |
0.0036 |
| 191 |
PULMONARY ALVEOLAR HAEMORRHAGE |
20 |
0.0036 |
| 192 |
BRAIN DEATH |
11 |
0.0036 |
| 193 |
KIDNEY TRANSPLANT REJECTION |
17 |
0.0035 |
| 194 |
ATYPICAL MYCOBACTERIAL INFECTION |
5 |
0.0035 |
| 195 |
B-CELL LYMPHOMA |
12 |
0.0035 |
| 196 |
GLOMERULAR FILTRATION RATE ABNORMAL |
5 |
0.0035 |
| 197 |
CATAPLEXY |
5 |
0.0035 |
| 198 |
READING DISORDER |
8 |
0.0035 |
| 199 |
RASH MACULO-PAPULAR |
77 |
0.0035 |
| 200 |
DERMATITIS EXFOLIATIVE GENERALISED |
12 |
0.0034 |
| 201 |
EXTREMITY NECROSIS |
6 |
0.0034 |
| 202 |
COVID-19 PNEUMONIA |
39 |
0.0033 |
| 203 |
SOFT TISSUE INFECTION |
6 |
0.0033 |
| 204 |
BK VIRUS INFECTION |
11 |
0.0033 |
| 205 |
ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC |
5 |
0.0033 |
| 206 |
PARTIAL SEIZURES |
17 |
0.0032 |
| 207 |
TRANSPLANT REJECTION |
26 |
0.0032 |
| 208 |
OTOTOXICITY |
6 |
0.0032 |
| 209 |
CHOLESTASIS |
62 |
0.0032 |
| 210 |
VENOOCCLUSIVE DISEASE |
8 |
0.0032 |
| 211 |
DRUG RESISTANCE |
82 |
0.0032 |
| 212 |
BLOOD PRESSURE DIASTOLIC ABNORMAL |
8 |
0.0031 |
| 213 |
COMPLICATIONS OF TRANSPLANTED KIDNEY |
7 |
0.0031 |
| 214 |
FAILURE TO THRIVE |
16 |
0.0031 |
| 215 |
SERUM FERRITIN INCREASED |
16 |
0.0030 |
| 216 |
ACUTE MYELOID LEUKAEMIA |
47 |
0.0030 |
| 217 |
ACUTE RESPIRATORY FAILURE |
57 |
0.0030 |
| 218 |
SCHIZOPHRENIA |
36 |
0.0030 |
| 219 |
SARCOIDOSIS |
14 |
0.0029 |
| 220 |
CLOSTRIDIUM DIFFICILE COLITIS |
31 |
0.0029 |
| 221 |
VARICELLA ZOSTER VIRUS INFECTION |
6 |
0.0029 |
| 222 |
HYPOGAMMAGLOBULINAEMIA |
19 |
0.0029 |
| 223 |
BREAST DISCHARGE |
5 |
0.0029 |
| 224 |
NASAL POLYPS |
14 |
0.0028 |
| 225 |
ACUTE GRAFT VERSUS HOST DISEASE |
13 |
0.0028 |
| 226 |
VENOOCCLUSIVE LIVER DISEASE |
14 |
0.0028 |
| 227 |
HYPERVOLAEMIA |
14 |
0.0028 |
| 228 |
ABSCESS LIMB |
12 |
0.0028 |
| 229 |
RESPIRATORY FAILURE |
202 |
0.0028 |
| 230 |
CHRONIC GRAFT VERSUS HOST DISEASE |
10 |
0.0028 |
| 231 |
URINARY TRACT INFECTION BACTERIAL |
7 |
0.0028 |
| 232 |
DRUG ERUPTION |
49 |
0.0028 |
| 233 |
SEPTIC SHOCK |
120 |
0.0028 |
| 234 |
BLOOD HIV RNA INCREASED |
5 |
0.0028 |
| 235 |
RENAL TUBULAR ACIDOSIS |
6 |
0.0027 |
| 236 |
INFECTION SUSCEPTIBILITY INCREASED |
6 |
0.0027 |
| 237 |
CUTANEOUS VASCULITIS |
10 |
0.0027 |
| 238 |
ENDOMETRIAL CANCER |
6 |
0.0027 |
| 239 |
CLOSTRIDIUM TEST POSITIVE |
6 |
0.0027 |
| 240 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
70 |
0.0027 |
| 241 |
RETROPERITONEAL HAEMATOMA |
6 |
0.0027 |
| 242 |
CHOLESTATIC LIVER INJURY |
6 |
0.0027 |
| 243 |
DUODENAL ULCER |
19 |
0.0027 |
| 244 |
DRUG LEVEL INCREASED |
44 |
0.0027 |
| 245 |
HIV INFECTION |
8 |
0.0027 |
| 246 |
VASCULAR DEVICE INFECTION |
12 |
0.0026 |
| 247 |
PROTEIN TOTAL INCREASED |
7 |
0.0026 |
| 248 |
DISSEMINATED INTRAVASCULAR COAGULATION |
37 |
0.0026 |
| 249 |
HAEMOLYSIS |
20 |
0.0026 |
| 250 |
HAEMOLYTIC URAEMIC SYNDROME |
6 |
0.0026 |
| 251 |
ANHEDONIA |
68 |
0.0026 |
| 252 |
ECONOMIC PROBLEM |
39 |
0.0026 |
| 253 |
OESOPHAGITIS |
28 |
0.0026 |
| 254 |
PATHOGEN RESISTANCE |
23 |
0.0025 |
| 255 |
EMPYEMA |
5 |
0.0025 |
| 256 |
PNEUMONIA VIRAL |
8 |
0.0025 |
| 257 |
ANORECTAL DISORDER |
5 |
0.0025 |
| 258 |
APLASTIC ANAEMIA |
13 |
0.0025 |
| 259 |
PLASMA CELL MYELOMA RECURRENT |
8 |
0.0025 |
| 260 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
69 |
0.0024 |
| 261 |
ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS |
6 |
0.0024 |
| 262 |
BLOOD IMMUNOGLOBULIN G DECREASED |
6 |
0.0024 |
| 263 |
CAPILLARY LEAK SYNDROME |
5 |
0.0024 |
| 264 |
HEPATIC ENZYME ABNORMAL |
12 |
0.0024 |
| 265 |
THROMBOCYTOPENIA |
269 |
0.0024 |
| 266 |
STEM CELL TRANSPLANT |
6 |
0.0024 |
| 267 |
IMMUNOSUPPRESSION |
21 |
0.0024 |
| 268 |
HISTIOCYTOSIS HAEMATOPHAGIC |
7 |
0.0024 |
| 269 |
ATYPICAL PNEUMONIA |
7 |
0.0023 |
| 270 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
8 |
0.0023 |
| 271 |
SHOCK HAEMORRHAGIC |
19 |
0.0023 |
| 272 |
PSEUDOMONAS INFECTION |
20 |
0.0023 |
| 273 |
PHYSICAL DECONDITIONING |
6 |
0.0023 |
| 274 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
6 |
0.0023 |
| 275 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
41 |
0.0023 |
| 276 |
CANDIDA INFECTION |
39 |
0.0023 |
| 277 |
PORTAL HYPERTENSION |
7 |
0.0023 |
| 278 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
6 |
0.0023 |
| 279 |
HEPATOTOXICITY |
50 |
0.0022 |
| 280 |
RENAL TUBULAR NECROSIS |
22 |
0.0022 |
| 281 |
BACTERIAL TEST POSITIVE |
5 |
0.0022 |
| 282 |
RENAL TRANSPLANT |
8 |
0.0022 |
| 283 |
ODYNOPHAGIA |
13 |
0.0022 |
| 284 |
OSTEOPENIA |
33 |
0.0022 |
| 285 |
CYTOMEGALOVIRUS COLITIS |
5 |
0.0022 |
| 286 |
LUNG INFILTRATION |
19 |
0.0021 |
| 287 |
BILIRUBIN CONJUGATED INCREASED |
5 |
0.0021 |
| 288 |
ESCHERICHIA URINARY TRACT INFECTION |
9 |
0.0021 |
| 289 |
LUNG NEOPLASM |
9 |
0.0021 |
| 290 |
MENINGITIS |
14 |
0.0021 |
| 291 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
8 |
0.0021 |
| 292 |
RETINAL VEIN OCCLUSION |
6 |
0.0021 |
| 293 |
RALES |
12 |
0.0021 |
| 294 |
NEUTROPENIA |
279 |
0.0020 |
| 295 |
HAEMATOLOGICAL INFECTION |
5 |
0.0020 |
| 296 |
COLITIS |
77 |
0.0020 |
| 297 |
BONE MARROW FAILURE |
41 |
0.0020 |
| 298 |
HAEMOLYTIC ANAEMIA |
18 |
0.0020 |
| 299 |
NEUTROPHIL COUNT DECREASED |
81 |
0.0020 |
| 300 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
7 |
0.0020 |
| 301 |
LYMPHOPENIA |
28 |
0.0020 |
| 302 |
END STAGE RENAL DISEASE |
36 |
0.0020 |
| 303 |
BLOOD PRESSURE DIASTOLIC INCREASED |
9 |
0.0019 |
| 304 |
DIASTOLIC DYSFUNCTION |
6 |
0.0019 |
| 305 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
16 |
0.0019 |
| 306 |
INVESTIGATION |
6 |
0.0019 |
| 307 |
ACUTE KIDNEY INJURY |
292 |
0.0019 |
| 308 |
CHRONIC LYMPHOCYTIC LEUKAEMIA |
9 |
0.0019 |
| 309 |
AMYLASE INCREASED |
7 |
0.0019 |
| 310 |
BLOOD BILIRUBIN INCREASED |
51 |
0.0019 |
| 311 |
GASTROINTESTINAL STROMAL TUMOUR |
5 |
0.0019 |
| 312 |
CARDIAC DYSFUNCTION |
7 |
0.0019 |
| 313 |
STEVENS-JOHNSON SYNDROME |
41 |
0.0018 |
| 314 |
HYPERKALAEMIA |
64 |
0.0018 |
| 315 |
PLASMA CELL MYELOMA |
71 |
0.0018 |
| 316 |
TUMOUR LYSIS SYNDROME |
16 |
0.0018 |
| 317 |
STAPHYLOCOCCAL INFECTION |
59 |
0.0018 |
| 318 |
ENDOTRACHEAL INTUBATION |
5 |
0.0018 |
| 319 |
CHOLANGITIS |
11 |
0.0018 |
| 320 |
HEPATIC FUNCTION ABNORMAL |
66 |
0.0018 |
| 321 |
LEUKOCYTOSIS |
32 |
0.0018 |
| 322 |
HYPOPHOSPHATAEMIA |
13 |
0.0018 |
| 323 |
SKIN PAPILLOMA |
7 |
0.0017 |
| 324 |
CYSTITIS HAEMORRHAGIC |
7 |
0.0017 |
| 325 |
HYPOXIA |
61 |
0.0017 |
| 326 |
NEPHROGENIC ANAEMIA |
8 |
0.0017 |
| 327 |
RENAL FUNCTION TEST ABNORMAL |
8 |
0.0017 |
| 328 |
GASTRITIS EROSIVE |
8 |
0.0017 |
| 329 |
SEPSIS |
191 |
0.0017 |
| 330 |
ERYTHEMA NODOSUM |
6 |
0.0017 |
| 331 |
PAPULE |
12 |
0.0017 |
| 332 |
HERPES SIMPLEX |
11 |
0.0017 |
| 333 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
8 |
0.0017 |
| 334 |
PLATELET COUNT DECREASED |
179 |
0.0017 |
| 335 |
RECALLED PRODUCT ADMINISTERED |
16 |
0.0017 |
| 336 |
HYPERLIPIDAEMIA |
20 |
0.0017 |
| 337 |
ANAL ABSCESS |
9 |
0.0017 |
| 338 |
HYPERCAPNIA |
5 |
0.0017 |
| 339 |
DRUG-INDUCED LIVER INJURY |
52 |
0.0017 |
| 340 |
BONE MARROW DISORDER |
5 |
0.0017 |
| 341 |
LIVER TRANSPLANT |
6 |
0.0016 |
| 342 |
CHOLELITHIASIS |
54 |
0.0016 |
| 343 |
STAPHYLOCOCCAL SEPSIS |
8 |
0.0016 |
| 344 |
CARDIAC MURMUR |
14 |
0.0016 |
| 345 |
CHEMOTHERAPY |
6 |
0.0016 |
| 346 |
PARANASAL SINUS DISCOMFORT |
6 |
0.0016 |
| 347 |
ABDOMINAL ABSCESS |
7 |
0.0016 |
| 348 |
DYSLIPIDAEMIA |
8 |
0.0016 |
| 349 |
BRAIN NEOPLASM MALIGNANT |
7 |
0.0016 |
| 350 |
ENTEROCOLITIS |
9 |
0.0016 |
| 351 |
IRON DEFICIENCY |
7 |
0.0016 |
| 352 |
PULMONARY TOXICITY |
11 |
0.0016 |
| 353 |
SUSPECTED OFF LABEL USE |
7 |
0.0015 |
| 354 |
LIVER ABSCESS |
5 |
0.0015 |
| 355 |
DISEASE COMPLICATION |
7 |
0.0015 |
| 356 |
IMMUNE THROMBOCYTOPENIA |
7 |
0.0015 |
| 357 |
BLOOD LACTIC ACID INCREASED |
8 |
0.0015 |
| 358 |
PNEUMONITIS |
41 |
0.0015 |
| 359 |
DIARRHOEA HAEMORRHAGIC |
14 |
0.0015 |
| 360 |
BLOOD PRESSURE DIASTOLIC DECREASED |
11 |
0.0015 |
| 361 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
14 |
0.0015 |
| 362 |
ELECTROLYTE IMBALANCE |
17 |
0.0015 |
| 363 |
FAECALOMA |
8 |
0.0015 |
| 364 |
HEPATIC FAILURE |
44 |
0.0015 |
| 365 |
LEUKOPENIA |
73 |
0.0015 |
| 366 |
APLASIA PURE RED CELL |
5 |
0.0015 |
| 367 |
PLEURAL EFFUSION |
88 |
0.0014 |
| 368 |
INTERSTITIAL LUNG DISEASE |
70 |
0.0014 |
| 369 |
HYPERTHERMIA |
11 |
0.0014 |
| 370 |
NECROSIS |
8 |
0.0014 |
| 371 |
SHOCK |
33 |
0.0014 |
| 372 |
APHTHOUS ULCER |
11 |
0.0014 |
| 373 |
LYMPHOCYTE COUNT DECREASED |
25 |
0.0014 |
| 374 |
HYPOPHAGIA |
36 |
0.0014 |
| 375 |
ISCHAEMIC STROKE |
25 |
0.0014 |
| 376 |
HAEMOGLOBIN ABNORMAL |
9 |
0.0014 |
| 377 |
BACTERIAL INFECTION |
26 |
0.0014 |
| 378 |
MOUTH ULCERATION |
29 |
0.0014 |
| 379 |
HYPOCALCAEMIA |
26 |
0.0014 |
| 380 |
RASH PUSTULAR |
10 |
0.0014 |
| 381 |
PULMONARY FUNCTION TEST DECREASED |
6 |
0.0014 |
| 382 |
EOSINOPHILIA |
24 |
0.0014 |
| 383 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
75 |
0.0014 |
| 384 |
CEREBRAL DISORDER |
10 |
0.0014 |
| 385 |
SKIN NECROSIS |
7 |
0.0013 |
| 386 |
SKIN MASS |
9 |
0.0013 |
| 387 |
QUALITY OF LIFE DECREASED |
18 |
0.0013 |
| 388 |
PERICARDIAL EFFUSION |
31 |
0.0013 |
| 389 |
FULL BLOOD COUNT DECREASED |
27 |
0.0013 |
| 390 |
ALTERED STATE OF CONSCIOUSNESS |
29 |
0.0013 |
| 391 |
NEPHROPATHY TOXIC |
15 |
0.0013 |
| 392 |
HYDRONEPHROSIS |
10 |
0.0013 |
| 393 |
BLOOD PRESSURE SYSTOLIC INCREASED |
26 |
0.0013 |
| 394 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
21 |
0.0013 |
| 395 |
CATHETER SITE INFECTION |
5 |
0.0013 |
| 396 |
MYELODYSPLASTIC SYNDROME |
19 |
0.0013 |
| 397 |
PYREXIA |
453 |
0.0013 |
| 398 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
29 |
0.0013 |
| 399 |
GINGIVITIS |
7 |
0.0013 |
| 400 |
AUTOIMMUNE HEPATITIS |
9 |
0.0013 |
| 401 |
TOXIC SKIN ERUPTION |
13 |
0.0013 |
| 402 |
HYPOALBUMINAEMIA |
10 |
0.0013 |
| 403 |
DRUG LEVEL DECREASED |
13 |
0.0013 |
| 404 |
ALANINE AMINOTRANSFERASE INCREASED |
78 |
0.0013 |
| 405 |
JAUNDICE |
34 |
0.0013 |
| 406 |
RED BLOOD CELL COUNT DECREASED |
36 |
0.0013 |
| 407 |
NEUROTOXICITY |
22 |
0.0013 |
| 408 |
CANDIDIASIS |
5 |
0.0012 |
| 409 |
ATELECTASIS |
12 |
0.0012 |
| 410 |
SKIN LESION |
34 |
0.0012 |
| 411 |
INTERNATIONAL NORMALISED RATIO DECREASED |
5 |
0.0012 |
| 412 |
HEPATITIS ACUTE |
8 |
0.0012 |
| 413 |
INCORRECT DOSAGE ADMINISTERED |
6 |
0.0012 |
| 414 |
MYOSITIS |
11 |
0.0012 |
| 415 |
ARTHRITIS BACTERIAL |
5 |
0.0012 |
| 416 |
PNEUMONIA |
393 |
0.0012 |
| 417 |
LEG AMPUTATION |
5 |
0.0012 |
| 418 |
SPINAL COMPRESSION FRACTURE |
10 |
0.0012 |
| 419 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
30 |
0.0012 |
| 420 |
METABOLIC DISORDER |
7 |
0.0012 |
| 421 |
PROTEIN URINE PRESENT |
6 |
0.0012 |
| 422 |
CLOSTRIDIUM DIFFICILE INFECTION |
26 |
0.0012 |
| 423 |
RENAL FAILURE |
158 |
0.0012 |
| 424 |
ENDOCARDITIS |
6 |
0.0012 |
| 425 |
LEUKAEMIA |
11 |
0.0012 |
| 426 |
GASTROENTERITIS |
17 |
0.0012 |
| 427 |
HEPATITIS CHOLESTATIC |
7 |
0.0012 |
| 428 |
MYOPATHY |
10 |
0.0012 |
| 429 |
PANCREATITIS ACUTE |
26 |
0.0012 |
| 430 |
ASCITES |
34 |
0.0012 |
| 431 |
ENCEPHALITIS |
8 |
0.0012 |
| 432 |
PYELONEPHRITIS |
10 |
0.0012 |
| 433 |
ADRENAL INSUFFICIENCY |
14 |
0.0012 |
| 434 |
DERMATITIS ACNEIFORM |
7 |
0.0011 |
| 435 |
ASPARTATE AMINOTRANSFERASE INCREASED |
61 |
0.0011 |
| 436 |
LIVER INJURY |
28 |
0.0011 |
| 437 |
IMMUNODEFICIENCY |
17 |
0.0011 |
| 438 |
BLOOD CREATININE INCREASED |
74 |
0.0011 |
| 439 |
CELLULITIS |
57 |
0.0011 |
| 440 |
HEPATOCELLULAR INJURY |
16 |
0.0011 |
| 441 |
TRANSAMINASES INCREASED |
25 |
0.0011 |
| 442 |
LUNG DISORDER |
55 |
0.0011 |
| 443 |
STRESS FRACTURE |
6 |
0.0011 |
| 444 |
RENAL IMPAIRMENT |
93 |
0.0011 |
| 445 |
LIVER DISORDER |
49 |
0.0011 |
| 446 |
HYPOKALAEMIA |
51 |
0.0011 |
| 447 |
WHITE BLOOD CELL COUNT ABNORMAL |
7 |
0.0011 |
| 448 |
COVID-19 |
192 |
0.0011 |
| 449 |
ANAEMIA |
208 |
0.0011 |
| 450 |
DYSPNOEA EXERTIONAL |
41 |
0.0011 |
| 451 |
FUNGAL INFECTION |
36 |
0.0011 |
| 452 |
HYPERGLYCAEMIA |
39 |
0.0011 |
| 453 |
MUCOSAL INFLAMMATION |
28 |
0.0011 |
| 454 |
ORAL CANDIDIASIS |
14 |
0.0011 |
| 455 |
WHITE BLOOD CELL COUNT DECREASED |
115 |
0.0011 |
| 456 |
GLOMERULAR FILTRATION RATE DECREASED |
13 |
0.0011 |
| 457 |
BLOOD MAGNESIUM DECREASED |
9 |
0.0010 |
| 458 |
DEVICE RELATED INFECTION |
16 |
0.0010 |
| 459 |
OXYGEN SATURATION DECREASED |
58 |
0.0010 |
| 460 |
HYPOVOLAEMIA |
6 |
0.0010 |
| 461 |
HYPERTRIGLYCERIDAEMIA |
6 |
0.0010 |
| 462 |
SPLENOMEGALY |
12 |
0.0010 |
| 463 |
BONE DENSITY DECREASED |
32 |
0.0010 |
| 464 |
DECREASED ACTIVITY |
11 |
0.0010 |
| 465 |
BLOOD UREA INCREASED |
17 |
0.0010 |
| 466 |
BLOOD ALBUMIN DECREASED |
8 |
0.0010 |
| 467 |
PULMONARY MASS |
15 |
0.0010 |
| 468 |
HYPERAMMONAEMIA |
5 |
0.0010 |
| 469 |
OSTEOPOROSIS |
41 |
0.0010 |
| 470 |
PLATELET COUNT ABNORMAL |
6 |
0.0010 |
| 471 |
MALNUTRITION |
11 |
0.0010 |
| 472 |
HEPATIC ENZYME INCREASED |
67 |
0.0010 |
| 473 |
RESPIRATORY DISTRESS |
27 |
0.0010 |
| 474 |
LIVER FUNCTION TEST INCREASED |
21 |
0.0010 |
| 475 |
NEUTROPHIL COUNT INCREASED |
10 |
0.0010 |
| 476 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
10 |
0.0010 |
| 477 |
MENTAL STATUS CHANGES |
27 |
0.0010 |
| 478 |
LYMPHOMA |
15 |
0.0010 |
| 479 |
ERYTHEMA MULTIFORME |
9 |
0.0010 |
| 480 |
FAECES SOFT |
7 |
0.0010 |
| 481 |
PETECHIAE |
10 |
0.0010 |
| 482 |
INTENTIONAL UNDERDOSE |
7 |
0.0010 |
| 483 |
DRUG INTERACTION |
152 |
0.0010 |
| 484 |
TACHYPNOEA |
13 |
0.0010 |
| 485 |
OFF LABEL USE |
836 |
0.0010 |
| 486 |
MELAENA |
21 |
0.0010 |
| 487 |
CHRONIC KIDNEY DISEASE |
72 |
0.0009 |
| 488 |
DISEASE RECURRENCE |
45 |
0.0009 |
| 489 |
TREATMENT FAILURE |
78 |
0.0009 |
| 490 |
TASTE DISORDER |
19 |
0.0009 |
| 491 |
MULTI-ORGAN FAILURE |
16 |
0.0009 |
| 492 |
BLOOD POTASSIUM INCREASED |
15 |
0.0009 |
| 493 |
CHILLS |
108 |
0.0009 |
| 494 |
RENAL FAILURE ACUTE |
39 |
0.0009 |
| 495 |
CONDITION AGGRAVATED |
279 |
0.0009 |
| 496 |
WOUND INFECTION |
10 |
0.0009 |
| 497 |
MULTIPLE FRACTURES |
15 |
0.0009 |
| 498 |
DYSGRAPHIA |
6 |
0.0009 |
| 499 |
CORONAVIRUS INFECTION |
6 |
0.0009 |
| 500 |
PURPURA |
8 |
0.0009 |
| 501 |
HYPERCALCAEMIA |
11 |
0.0009 |
| 502 |
ANAL INCONTINENCE |
8 |
0.0009 |
| 503 |
HAEMOGLOBIN DECREASED |
91 |
0.0009 |
| 504 |
REBOUND EFFECT |
10 |
0.0009 |
| 505 |
ECCHYMOSIS |
6 |
0.0009 |
| 506 |
RHINITIS |
7 |
0.0009 |
| 507 |
UROSEPSIS |
8 |
0.0009 |
| 508 |
BLOOD URIC ACID INCREASED |
5 |
0.0009 |
| 509 |
BONE LOSS |
13 |
0.0009 |
| 510 |
HYPERTRANSAMINASAEMIA |
6 |
0.0009 |
| 511 |
DISEASE PROGRESSION |
102 |
0.0009 |
| 512 |
HYPOMAGNESAEMIA |
12 |
0.0009 |
| 513 |
DEEP VEIN THROMBOSIS |
56 |
0.0009 |
| 514 |
TRANSFUSION |
9 |
0.0009 |
| 515 |
BLOOD COUNT ABNORMAL |
13 |
0.0009 |
| 516 |
NEPHROPATHY |
8 |
0.0009 |
| 517 |
POLYURIA |
7 |
0.0009 |
| 518 |
FULL BLOOD COUNT ABNORMAL |
9 |
0.0009 |
| 519 |
SQUAMOUS CELL CARCINOMA |
8 |
0.0008 |
| 520 |
SEASONAL ALLERGY |
12 |
0.0008 |
| 521 |
GENERALISED TONIC-CLONIC SEIZURE |
14 |
0.0008 |
| 522 |
DIALYSIS |
12 |
0.0008 |
| 523 |
HERPES ZOSTER |
48 |
0.0008 |
| 524 |
HEPATITIS B |
5 |
0.0008 |
| 525 |
DERMATITIS BULLOUS |
6 |
0.0008 |
| 526 |
HOSPICE CARE |
8 |
0.0008 |
| 527 |
HAEMORRHAGE INTRACRANIAL |
12 |
0.0008 |
| 528 |
CENTRAL NERVOUS SYSTEM LESION |
11 |
0.0008 |
| 529 |
C-REACTIVE PROTEIN INCREASED |
29 |
0.0008 |
| 530 |
INFUSION SITE SWELLING |
5 |
0.0008 |
| 531 |
RENAL DISORDER |
37 |
0.0008 |
| 532 |
LIVER FUNCTION TEST ABNORMAL |
23 |
0.0008 |
| 533 |
MUSCLE ATROPHY |
10 |
0.0008 |
| 534 |
MYOCARDITIS |
9 |
0.0008 |
| 535 |
LIPASE INCREASED |
6 |
0.0008 |
| 536 |
HEPATITIS |
20 |
0.0008 |
| 537 |
RENAL FAILURE CHRONIC |
6 |
0.0008 |
| 538 |
GOUT |
14 |
0.0008 |
| 539 |
OSTEOMYELITIS |
14 |
0.0008 |
| 540 |
TENDERNESS |
8 |
0.0008 |
| 541 |
PULMONARY HAEMORRHAGE |
6 |
0.0008 |
| 542 |
TOOTH INFECTION |
10 |
0.0008 |
| 543 |
NEUROPATHY PERIPHERAL |
72 |
0.0008 |
| 544 |
PNEUMOTHORAX |
12 |
0.0008 |
| 545 |
HAEMATOCRIT DECREASED |
15 |
0.0008 |
| 546 |
HAEMOPTYSIS |
21 |
0.0008 |
| 547 |
ATRIAL FLUTTER |
6 |
0.0008 |
| 548 |
PRESCRIBED UNDERDOSE |
15 |
0.0008 |
| 549 |
VIRAL INFECTION |
25 |
0.0008 |
| 550 |
CARDIAC FAILURE ACUTE |
5 |
0.0007 |
| 551 |
LEFT VENTRICULAR DYSFUNCTION |
5 |
0.0007 |
| 552 |
LOCALISED INFECTION |
18 |
0.0007 |
| 553 |
BLOOD SODIUM DECREASED |
14 |
0.0007 |
| 554 |
FEEDING DISORDER |
15 |
0.0007 |
| 555 |
PRODUCT TASTE ABNORMAL |
10 |
0.0007 |
| 556 |
DECUBITUS ULCER |
6 |
0.0007 |
| 557 |
HAEMATOMA |
19 |
0.0007 |
| 558 |
SUPRAVENTRICULAR TACHYCARDIA |
7 |
0.0007 |
| 559 |
ASPIRATION |
8 |
0.0007 |
| 560 |
ATRIAL FIBRILLATION |
71 |
0.0007 |
| 561 |
APHASIA |
22 |
0.0007 |
| 562 |
UPPER-AIRWAY COUGH SYNDROME |
6 |
0.0007 |
| 563 |
ACUTE CORONARY SYNDROME |
6 |
0.0007 |
| 564 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
8 |
0.0007 |
| 565 |
DIZZINESS POSTURAL |
7 |
0.0007 |
| 566 |
PNEUMONIA ASPIRATION |
18 |
0.0007 |
| 567 |
HAEMODIALYSIS |
6 |
0.0007 |
| 568 |
PRODUCT USE IN UNAPPROVED INDICATION |
177 |
0.0007 |
| 569 |
TREATMENT NONCOMPLIANCE |
39 |
0.0007 |
| 570 |
INTESTINAL PERFORATION |
8 |
0.0007 |
| 571 |
HEPATOMEGALY |
7 |
0.0007 |
| 572 |
ABDOMINAL PAIN LOWER |
18 |
0.0007 |
| 573 |
LABORATORY TEST ABNORMAL |
21 |
0.0007 |
| 574 |
FACE OEDEMA |
12 |
0.0007 |
| 575 |
PSYCHOTIC DISORDER |
21 |
0.0007 |
| 576 |
HYPONATRAEMIA |
40 |
0.0007 |
| 577 |
STOMATITIS |
43 |
0.0007 |
| 578 |
INFECTION |
102 |
0.0007 |
| 579 |
SINUS TACHYCARDIA |
10 |
0.0007 |
| 580 |
SUBDURAL HAEMATOMA |
10 |
0.0007 |
| 581 |
HEPATIC STEATOSIS |
13 |
0.0007 |
| 582 |
SKIN ULCER |
18 |
0.0007 |
| 583 |
DIPLOPIA |
18 |
0.0007 |
| 584 |
PULMONARY OEDEMA |
31 |
0.0007 |
| 585 |
METABOLIC ACIDOSIS |
22 |
0.0007 |
| 586 |
TACHYCARDIA |
61 |
0.0007 |
| 587 |
URINE OUTPUT DECREASED |
6 |
0.0007 |
| 588 |
NIGHT SWEATS |
22 |
0.0007 |
| 589 |
PULMONARY CONGESTION |
9 |
0.0007 |
| 590 |
DIARRHOEA |
437 |
0.0007 |
| 591 |
VENTRICULAR EXTRASYSTOLES |
7 |
0.0007 |
| 592 |
BLOOD PRESSURE FLUCTUATION |
16 |
0.0007 |
| 593 |
ACUTE HEPATIC FAILURE |
9 |
0.0007 |
| 594 |
HAEMODYNAMIC INSTABILITY |
5 |
0.0007 |
| 595 |
INTENTIONAL PRODUCT USE ISSUE |
57 |
0.0007 |
| 596 |
GRAND MAL CONVULSION |
6 |
0.0006 |
| 597 |
SPINAL FRACTURE |
13 |
0.0006 |
| 598 |
LACTIC ACIDOSIS |
21 |
0.0006 |
| 599 |
GENERALISED OEDEMA |
8 |
0.0006 |
| 600 |
ACUTE MYOCARDIAL INFARCTION |
19 |
0.0006 |
| 601 |
HEPATIC ENCEPHALOPATHY |
6 |
0.0006 |
| 602 |
PULMONARY THROMBOSIS |
7 |
0.0006 |
| 603 |
THERAPY PARTIAL RESPONDER |
10 |
0.0006 |
| 604 |
FLANK PAIN |
6 |
0.0006 |
| 605 |
GASTROINTESTINAL INFLAMMATION |
5 |
0.0006 |
| 606 |
DECREASED APPETITE |
148 |
0.0006 |
| 607 |
BODY TEMPERATURE INCREASED |
13 |
0.0006 |
| 608 |
RASH |
277 |
0.0006 |
| 609 |
COUGH |
178 |
0.0006 |
| 610 |
BRAIN OEDEMA |
8 |
0.0006 |
| 611 |
PARALYSIS |
9 |
0.0006 |
| 612 |
SENSORY DISTURBANCE |
10 |
0.0006 |
| 613 |
INFUSION RELATED REACTION |
41 |
0.0006 |
| 614 |
MITRAL VALVE INCOMPETENCE |
7 |
0.0006 |
| 615 |
FLUID OVERLOAD |
9 |
0.0006 |
| 616 |
AUTOIMMUNE DISORDER |
6 |
0.0006 |
| 617 |
OEDEMA PERIPHERAL |
75 |
0.0006 |
| 618 |
SCAB |
7 |
0.0006 |
| 619 |
DEAFNESS |
16 |
0.0006 |
| 620 |
MYELOSUPPRESSION |
22 |
0.0006 |
| 621 |
OSTEONECROSIS |
20 |
0.0006 |
| 622 |
GASTRITIS |
16 |
0.0006 |
| 623 |
PRODUCTIVE COUGH |
29 |
0.0006 |
| 624 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
24 |
0.0006 |
| 625 |
HOSPITALISATION |
93 |
0.0006 |
| 626 |
INABILITY TO AFFORD MEDICATION |
6 |
0.0006 |
| 627 |
BLOOD PRESSURE ABNORMAL |
12 |
0.0006 |
| 628 |
EMOTIONAL DISTRESS |
73 |
0.0006 |
| 629 |
VASCULITIS |
7 |
0.0006 |
| 630 |
WHITE BLOOD CELL COUNT INCREASED |
23 |
0.0006 |
| 631 |
BRAIN INJURY |
6 |
0.0006 |
| 632 |
HEART RATE DECREASED |
21 |
0.0006 |
| 633 |
GENERAL PHYSICAL HEALTH DETERIORATION |
69 |
0.0006 |
| 634 |
INTERNATIONAL NORMALISED RATIO INCREASED |
17 |
0.0006 |
| 635 |
HYPOTENSION |
119 |
0.0006 |
| 636 |
SINUS CONGESTION |
8 |
0.0006 |
| 637 |
INSURANCE ISSUE |
9 |
0.0006 |
| 638 |
EPISTAXIS |
44 |
0.0006 |
| 639 |
FRACTURE |
11 |
0.0006 |
| 640 |
VOMITING |
273 |
0.0006 |
| 641 |
FOOT FRACTURE |
11 |
0.0006 |
| 642 |
EJECTION FRACTION DECREASED |
9 |
0.0006 |
| 643 |
PULMONARY HYPERTENSION |
12 |
0.0006 |
| 644 |
RESPIRATORY TRACT INFECTION |
15 |
0.0006 |
| 645 |
MASS |
8 |
0.0006 |
| 646 |
FOLLICULITIS |
6 |
0.0006 |
| 647 |
BLOOD TEST ABNORMAL |
8 |
0.0006 |
| 648 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
5 |
0.0006 |
| 649 |
BLOOD POTASSIUM DECREASED |
17 |
0.0006 |
| 650 |
ILEUS |
7 |
0.0006 |
| 651 |
DEHYDRATION |
75 |
0.0006 |
| 652 |
CARDIOGENIC SHOCK |
8 |
0.0006 |
| 653 |
DERMATITIS ALLERGIC |
7 |
0.0006 |
| 654 |
SKIN LACERATION |
6 |
0.0006 |
| 655 |
PRODUCT PRESCRIBING ISSUE |
12 |
0.0006 |
| 656 |
GASTROINTESTINAL HAEMORRHAGE |
46 |
0.0005 |
| 657 |
NEPHROLITHIASIS |
25 |
0.0005 |
| 658 |
IRON DEFICIENCY ANAEMIA |
5 |
0.0005 |
| 659 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
26 |
0.0005 |
| 660 |
CONSTIPATION |
117 |
0.0005 |
| 661 |
SKIN INFECTION |
6 |
0.0005 |
| 662 |
RIB FRACTURE |
11 |
0.0005 |
| 663 |
OEDEMA |
29 |
0.0005 |
| 664 |
PRESYNCOPE |
13 |
0.0005 |
| 665 |
EYE INFECTION |
6 |
0.0005 |
| 666 |
PANCREATITIS |
28 |
0.0005 |
| 667 |
DYSPNOEA |
299 |
0.0005 |
| 668 |
ELECTROCARDIOGRAM QT PROLONGED |
19 |
0.0005 |
| 669 |
RHABDOMYOLYSIS |
22 |
0.0005 |
| 670 |
PRODUCT AVAILABILITY ISSUE |
12 |
0.0005 |
| 671 |
CONTUSION |
50 |
0.0005 |
| 672 |
DRUG INTOLERANCE |
50 |
0.0005 |
| 673 |
NAUSEA |
408 |
0.0005 |
| 674 |
IMPAIRED GASTRIC EMPTYING |
7 |
0.0005 |
| 675 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
15 |
0.0005 |
| 676 |
VISUAL ACUITY REDUCED |
17 |
0.0005 |
| 677 |
BODY TEMPERATURE DECREASED |
5 |
0.0005 |
| 678 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
11 |
0.0005 |
| 679 |
BLOOD IRON DECREASED |
6 |
0.0005 |
| 680 |
DIVERTICULITIS |
14 |
0.0005 |
| 681 |
GALLBLADDER DISORDER |
9 |
0.0005 |
| 682 |
CHOLECYSTITIS |
6 |
0.0005 |
| 683 |
RESPIRATORY TRACT CONGESTION |
8 |
0.0005 |
| 684 |
MYOCLONUS |
6 |
0.0005 |
| 685 |
PREMATURE DELIVERY |
8 |
0.0005 |
| 686 |
INFLUENZA |
56 |
0.0005 |
| 687 |
WRIST FRACTURE |
6 |
0.0005 |
| 688 |
UPPER RESPIRATORY TRACT INFECTION |
23 |
0.0005 |
| 689 |
BLOOD PRESSURE INCREASED |
76 |
0.0005 |
| 690 |
HAEMATURIA |
17 |
0.0005 |
| 691 |
BONE DISORDER |
9 |
0.0005 |
| 692 |
MOTOR DYSFUNCTION |
5 |
0.0005 |
| 693 |
CARDIOMEGALY |
6 |
0.0005 |
| 694 |
CHROMATURIA |
11 |
0.0005 |
| 695 |
PULMONARY EMBOLISM |
46 |
0.0005 |
| 696 |
PHARYNGITIS |
6 |
0.0005 |
| 697 |
EYE DISCHARGE |
5 |
0.0005 |
| 698 |
RASH ERYTHEMATOUS |
23 |
0.0005 |
| 699 |
COAGULOPATHY |
8 |
0.0005 |
| 700 |
ASTHENIA |
180 |
0.0005 |
| 701 |
BONE PAIN |
28 |
0.0005 |
| 702 |
BLOOD URINE PRESENT |
9 |
0.0005 |
| 703 |
FLUID RETENTION |
24 |
0.0005 |
| 704 |
LOWER LIMB FRACTURE |
9 |
0.0005 |
| 705 |
HYPERTENSION |
99 |
0.0005 |
| 706 |
INFUSION SITE PAIN |
6 |
0.0005 |
| 707 |
RECTAL HAEMORRHAGE |
20 |
0.0005 |
| 708 |
ERUCTATION |
9 |
0.0005 |
| 709 |
PRESCRIBED OVERDOSE |
9 |
0.0005 |
| 710 |
DYSPHAGIA |
44 |
0.0005 |
| 711 |
HAEMORRHOIDS |
9 |
0.0005 |
| 712 |
CARDIAC FAILURE |
37 |
0.0005 |
| 713 |
IMMUNE SYSTEM DISORDER |
6 |
0.0005 |
| 714 |
CARDIO-RESPIRATORY ARREST |
19 |
0.0005 |
| 715 |
SARS-COV-2 TEST POSITIVE |
6 |
0.0005 |
| 716 |
HEART RATE INCREASED |
45 |
0.0005 |
| 717 |
CHEST PAIN |
84 |
0.0005 |
| 718 |
NEURALGIA |
11 |
0.0005 |
| 719 |
EAR INFECTION |
12 |
0.0005 |
| 720 |
LUNG INFECTION |
7 |
0.0005 |
| 721 |
CEREBRAL INFARCTION |
11 |
0.0004 |
| 722 |
CARDIAC ARREST |
37 |
0.0004 |
| 723 |
BRAIN FOG |
7 |
0.0004 |
| 724 |
GASTROINTESTINAL DISORDER |
40 |
0.0004 |
| 725 |
BRONCHITIS |
33 |
0.0004 |
| 726 |
INFLAMMATION |
23 |
0.0004 |
| 727 |
THERAPY NON-RESPONDER |
20 |
0.0004 |
| 728 |
GASTROENTERITIS VIRAL |
8 |
0.0004 |
| 729 |
RASH PRURITIC |
24 |
0.0004 |
| 730 |
UVEITIS |
6 |
0.0004 |
| 731 |
URINARY TRACT INFECTION |
75 |
0.0004 |
| 732 |
ABSCESS |
7 |
0.0004 |
| 733 |
MICTURITION URGENCY |
5 |
0.0004 |
| 734 |
RHINORRHOEA |
28 |
0.0004 |
| 735 |
MUSCULAR WEAKNESS |
49 |
0.0004 |
| 736 |
DYSGEUSIA |
32 |
0.0004 |
| 737 |
APHONIA |
6 |
0.0004 |
| 738 |
SKIN REACTION |
6 |
0.0004 |
| 739 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
22 |
0.0004 |
| 740 |
ABDOMINAL DISTENSION |
44 |
0.0004 |
| 741 |
DRY EYE |
21 |
0.0004 |
| 742 |
PRODUCT PRESCRIBING ERROR |
10 |
0.0004 |
| 743 |
SKIN DISORDER |
14 |
0.0004 |
| 744 |
WEIGHT DECREASED |
117 |
0.0004 |
| 745 |
HAEMATOCHEZIA |
23 |
0.0004 |
| 746 |
PARAESTHESIA ORAL |
6 |
0.0004 |
| 747 |
FAECES DISCOLOURED |
9 |
0.0004 |
| 748 |
CONFUSIONAL STATE |
67 |
0.0004 |
| 749 |
SKIN DISCOLOURATION |
19 |
0.0004 |
| 750 |
DYSSTASIA |
12 |
0.0004 |
| 751 |
ABDOMINAL PAIN |
95 |
0.0004 |
| 752 |
ANXIETY |
116 |
0.0004 |
| 753 |
CARDIOMYOPATHY |
6 |
0.0004 |
| 754 |
WHEEZING |
24 |
0.0004 |
| 755 |
FATIGUE |
314 |
0.0004 |
| 756 |
ORTHOSTATIC HYPOTENSION |
7 |
0.0004 |
| 757 |
ORAL PAIN |
9 |
0.0004 |
| 758 |
THERAPEUTIC RESPONSE UNEXPECTED |
18 |
0.0004 |
| 759 |
RESPIRATORY DISORDER |
12 |
0.0004 |
| 760 |
LETHARGY |
23 |
0.0004 |
| 761 |
OROPHARYNGEAL PAIN |
37 |
0.0004 |
| 762 |
AMNESIA |
26 |
0.0004 |
| 763 |
LYMPHADENOPATHY |
14 |
0.0004 |
| 764 |
DIABETES MELLITUS INADEQUATE CONTROL |
7 |
0.0004 |
| 765 |
DYSPHONIA |
23 |
0.0004 |
| 766 |
TOXICITY TO VARIOUS AGENTS |
66 |
0.0004 |
| 767 |
THERAPY CESSATION |
20 |
0.0004 |
| 768 |
ABDOMINAL DISCOMFORT |
65 |
0.0004 |
| 769 |
RASH GENERALISED |
10 |
0.0004 |
| 770 |
TOOTH LOSS |
8 |
0.0004 |
| 771 |
HYPERSOMNIA |
11 |
0.0004 |
| 772 |
RESTLESSNESS |
14 |
0.0004 |
| 773 |
CYANOSIS |
6 |
0.0004 |
| 774 |
DIABETES MELLITUS |
29 |
0.0004 |
| 775 |
ANKYLOSING SPONDYLITIS |
5 |
0.0004 |
| 776 |
ABDOMINAL PAIN UPPER |
78 |
0.0004 |
| 777 |
PALPITATIONS |
44 |
0.0004 |
| 778 |
DEATH |
323 |
0.0004 |
| 779 |
MIDDLE INSOMNIA |
7 |
0.0004 |
| 780 |
DELIRIUM |
13 |
0.0004 |
| 781 |
IMPAIRED WORK ABILITY |
8 |
0.0004 |
| 782 |
GASTROOESOPHAGEAL REFLUX DISEASE |
30 |
0.0004 |
| 783 |
SKIN CANCER |
8 |
0.0004 |
| 784 |
CHEST DISCOMFORT |
38 |
0.0004 |
| 785 |
LIMB INJURY |
10 |
0.0004 |
| 786 |
LUNG NEOPLASM MALIGNANT |
15 |
0.0004 |
| 787 |
POST PROCEDURAL COMPLICATION |
7 |
0.0004 |
| 788 |
PERIPHERAL SWELLING |
56 |
0.0004 |
| 789 |
NEOPLASM MALIGNANT |
24 |
0.0004 |
| 790 |
ILLNESS |
37 |
0.0004 |
| 791 |
ORAL HERPES |
7 |
0.0004 |
| 792 |
PERICARDITIS |
6 |
0.0004 |
| 793 |
PRODUCT DOSE OMISSION ISSUE |
105 |
0.0004 |
| 794 |
RASH PAPULAR |
8 |
0.0004 |
| 795 |
FOETAL EXPOSURE DURING PREGNANCY |
29 |
0.0004 |
| 796 |
KIDNEY INFECTION |
7 |
0.0004 |
| 797 |
TYPE 2 DIABETES MELLITUS |
12 |
0.0004 |
| 798 |
DISABILITY |
7 |
0.0004 |
| 799 |
BACK PAIN |
82 |
0.0004 |
| 800 |
UPPER LIMB FRACTURE |
7 |
0.0004 |
| 801 |
HYPOGLYCAEMIA |
17 |
0.0004 |
| 802 |
VISION BLURRED |
48 |
0.0003 |
| 803 |
PARANOIA |
6 |
0.0003 |
| 804 |
MATERNAL EXPOSURE DURING PREGNANCY |
31 |
0.0003 |
| 805 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
10 |
0.0003 |
| 806 |
HYPERTHYROIDISM |
5 |
0.0003 |
| 807 |
DRY MOUTH |
28 |
0.0003 |
| 808 |
SWELLING |
32 |
0.0003 |
| 809 |
SINUSITIS |
35 |
0.0003 |
| 810 |
NASAL CONGESTION |
20 |
0.0003 |
| 811 |
TREMOR |
56 |
0.0003 |
| 812 |
PRODUCT USE ISSUE |
63 |
0.0003 |
| 813 |
CEREBRAL HAEMORRHAGE |
12 |
0.0003 |
| 814 |
THROAT TIGHTNESS |
9 |
0.0003 |
| 815 |
HALLUCINATION |
25 |
0.0003 |
| 816 |
HALLUCINATION, VISUAL |
7 |
0.0003 |
| 817 |
TOOTHACHE |
6 |
0.0003 |
| 818 |
URINARY RETENTION |
11 |
0.0003 |
| 819 |
SEIZURE |
38 |
0.0003 |
| 820 |
EATING DISORDER |
7 |
0.0003 |
| 821 |
EPILEPSY |
10 |
0.0003 |
| 822 |
DRUG INEFFECTIVE |
429 |
0.0003 |
| 823 |
BLOOD GLUCOSE ABNORMAL |
6 |
0.0003 |
| 824 |
OSTEONECROSIS OF JAW |
8 |
0.0003 |
| 825 |
PAIN |
198 |
0.0003 |
| 826 |
BLISTER |
18 |
0.0003 |
| 827 |
TUBULOINTERSTITIAL NEPHRITIS |
6 |
0.0003 |
| 828 |
PHOTOPHOBIA |
6 |
0.0003 |
| 829 |
DYSARTHRIA |
12 |
0.0003 |
| 830 |
PAIN IN JAW |
9 |
0.0003 |
| 831 |
HAEMATEMESIS |
8 |
0.0003 |
| 832 |
TOOTH DISORDER |
7 |
0.0003 |
| 833 |
CYSTITIS |
10 |
0.0003 |
| 834 |
HYPERSENSITIVITY |
58 |
0.0003 |
| 835 |
THROAT IRRITATION |
14 |
0.0003 |
| 836 |
MUSCLE SPASMS |
57 |
0.0003 |
| 837 |
DIZZINESS |
152 |
0.0003 |
| 838 |
UNEVALUABLE EVENT |
23 |
0.0003 |
| 839 |
URINARY INCONTINENCE |
9 |
0.0003 |
| 840 |
INFLUENZA LIKE ILLNESS |
25 |
0.0003 |
| 841 |
CATARACT |
18 |
0.0003 |
| 842 |
BALANCE DISORDER |
26 |
0.0003 |
| 843 |
CARDIAC FAILURE CONGESTIVE |
24 |
0.0003 |
| 844 |
THROMBOSIS |
24 |
0.0003 |
| 845 |
HEADACHE |
187 |
0.0003 |
| 846 |
THERAPY INTERRUPTED |
21 |
0.0003 |
| 847 |
COLITIS ULCERATIVE |
13 |
0.0003 |
| 848 |
NERVOUS SYSTEM DISORDER |
9 |
0.0003 |
| 849 |
POLLAKIURIA |
12 |
0.0003 |
| 850 |
GAIT DISTURBANCE |
55 |
0.0003 |
| 851 |
LOCAL SWELLING |
5 |
0.0003 |
| 852 |
DERMATITIS |
6 |
0.0003 |
| 853 |
NECK PAIN |
16 |
0.0003 |
| 854 |
BLOOD PRESSURE DECREASED |
19 |
0.0003 |
| 855 |
MALAISE |
125 |
0.0003 |
| 856 |
EYE PAIN |
16 |
0.0003 |
| 857 |
MALIGNANT NEOPLASM PROGRESSION |
29 |
0.0003 |
| 858 |
BLOOD TRIGLYCERIDES INCREASED |
5 |
0.0003 |
| 859 |
TINNITUS |
13 |
0.0003 |
| 860 |
INSOMNIA |
75 |
0.0003 |
| 861 |
AGEUSIA |
7 |
0.0003 |
| 862 |
THERAPEUTIC RESPONSE DECREASED |
17 |
0.0003 |
| 863 |
ILL-DEFINED DISORDER |
17 |
0.0003 |
| 864 |
DISORIENTATION |
11 |
0.0003 |
| 865 |
VAGINAL HAEMORRHAGE |
12 |
0.0003 |
| 866 |
MENTAL DISORDER |
12 |
0.0003 |
| 867 |
ACCIDENTAL OVERDOSE |
10 |
0.0003 |
| 868 |
PRURITUS |
105 |
0.0003 |
| 869 |
ANAPHYLACTIC SHOCK |
7 |
0.0003 |
| 870 |
UNRESPONSIVE TO STIMULI |
7 |
0.0003 |
| 871 |
BURNING SENSATION |
19 |
0.0003 |
| 872 |
LIP SWELLING |
9 |
0.0003 |
| 873 |
BLINDNESS |
11 |
0.0003 |
| 874 |
PHARMACEUTICAL PRODUCT COMPLAINT |
7 |
0.0003 |
| 875 |
RENAL INJURY |
8 |
0.0003 |
| 876 |
NASOPHARYNGITIS |
49 |
0.0003 |
| 877 |
MYALGIA |
45 |
0.0003 |
| 878 |
CONTRAINDICATED PRODUCT ADMINISTERED |
8 |
0.0003 |
| 879 |
BRADYCARDIA |
14 |
0.0003 |
| 880 |
URTICARIA |
44 |
0.0003 |
| 881 |
ADVERSE EVENT |
24 |
0.0003 |
| 882 |
OSTEOARTHRITIS |
11 |
0.0003 |
| 883 |
RASH MACULAR |
9 |
0.0003 |
| 884 |
EAR PAIN |
5 |
0.0003 |
| 885 |
JOINT SWELLING |
31 |
0.0003 |
| 886 |
WEIGHT INCREASED |
57 |
0.0003 |
| 887 |
ERYTHEMA |
52 |
0.0003 |
| 888 |
PROCEDURAL PAIN |
7 |
0.0003 |
| 889 |
FEELING COLD |
7 |
0.0003 |
| 890 |
HYPOTHYROIDISM |
8 |
0.0003 |
| 891 |
HIP FRACTURE |
8 |
0.0002 |
| 892 |
HYPOAESTHESIA |
37 |
0.0002 |
| 893 |
PANIC ATTACK |
9 |
0.0002 |
| 894 |
FLATULENCE |
14 |
0.0002 |
| 895 |
SWELLING FACE |
16 |
0.0002 |
| 896 |
DYSURIA |
9 |
0.0002 |
| 897 |
DYSPEPSIA |
24 |
0.0002 |
| 898 |
EYE SWELLING |
9 |
0.0002 |
| 899 |
EXPOSURE DURING PREGNANCY |
15 |
0.0002 |
| 900 |
INTESTINAL OBSTRUCTION |
9 |
0.0002 |
| 901 |
PAIN IN EXTREMITY |
70 |
0.0002 |
| 902 |
BLOOD CHOLESTEROL INCREASED |
11 |
0.0002 |
| 903 |
COGNITIVE DISORDER |
11 |
0.0002 |
| 904 |
ANAPHYLACTIC REACTION |
13 |
0.0002 |
| 905 |
ADVERSE DRUG REACTION |
21 |
0.0002 |
| 906 |
GASTRIC DISORDER |
8 |
0.0002 |
| 907 |
ARRHYTHMIA |
11 |
0.0002 |
| 908 |
ECZEMA |
12 |
0.0002 |
| 909 |
SPEECH DISORDER |
12 |
0.0002 |
| 910 |
FEMUR FRACTURE |
7 |
0.0002 |
| 911 |
FALL |
75 |
0.0002 |
| 912 |
GLOSSODYNIA |
5 |
0.0002 |
| 913 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
40 |
0.0002 |
| 914 |
ARTHRALGIA |
92 |
0.0002 |
| 915 |
SYNCOPE |
22 |
0.0002 |
| 916 |
LOSS OF CONSCIOUSNESS |
28 |
0.0002 |
| 917 |
MOVEMENT DISORDER |
7 |
0.0002 |
| 918 |
HYPERHIDROSIS |
28 |
0.0002 |
| 919 |
MEDICATION ERROR |
12 |
0.0002 |
| 920 |
WOUND |
6 |
0.0002 |
| 921 |
SKIN EXFOLIATION |
18 |
0.0002 |
| 922 |
VERTIGO |
13 |
0.0002 |
| 923 |
FEELING HOT |
13 |
0.0002 |
| 924 |
PRODUCT DOSE OMISSION IN ERROR |
6 |
0.0002 |
| 925 |
OCULAR HYPERAEMIA |
10 |
0.0002 |
| 926 |
EYE PRURITUS |
7 |
0.0002 |
| 927 |
DEPRESSION |
47 |
0.0002 |
| 928 |
ABASIA |
5 |
0.0002 |
| 929 |
PREMATURE BABY |
6 |
0.0002 |
| 930 |
PRODUCT DOSE OMISSION |
13 |
0.0002 |
| 931 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
7 |
0.0002 |
| 932 |
DISCOMFORT |
12 |
0.0002 |
| 933 |
DRY SKIN |
26 |
0.0002 |
| 934 |
SOMNOLENCE |
39 |
0.0002 |
| 935 |
ROAD TRAFFIC ACCIDENT |
8 |
0.0002 |
| 936 |
MUSCULOSKELETAL PAIN |
10 |
0.0002 |
| 937 |
ARTHRITIS |
15 |
0.0002 |
| 938 |
JOINT STIFFNESS |
5 |
0.0002 |
| 939 |
MOOD SWINGS |
6 |
0.0002 |
| 940 |
DISTURBANCE IN ATTENTION |
10 |
0.0002 |
| 941 |
SLEEP DISORDER |
13 |
0.0002 |
| 942 |
ARTHROPATHY |
10 |
0.0002 |
| 943 |
VISUAL IMPAIRMENT |
22 |
0.0002 |
| 944 |
AGITATION |
13 |
0.0002 |
| 945 |
INTENTIONAL DOSE OMISSION |
5 |
0.0002 |
| 946 |
CONVULSION |
10 |
0.0002 |
| 947 |
NEOPLASM PROGRESSION |
6 |
0.0002 |
| 948 |
ACNE |
13 |
0.0002 |
| 949 |
CEREBROVASCULAR ACCIDENT |
29 |
0.0002 |
| 950 |
UNDERDOSE |
12 |
0.0002 |
| 951 |
HAEMORRHAGE |
17 |
0.0002 |
| 952 |
DRUG DOSE OMISSION |
26 |
0.0002 |
| 953 |
LOWER RESPIRATORY TRACT INFECTION |
7 |
0.0002 |
| 954 |
SURGERY |
9 |
0.0002 |
| 955 |
NERVOUSNESS |
8 |
0.0002 |
| 956 |
PARAESTHESIA |
24 |
0.0002 |
| 957 |
IRRITABILITY |
9 |
0.0001 |
| 958 |
PRODUCT QUALITY ISSUE |
20 |
0.0001 |
| 959 |
COMA |
7 |
0.0001 |
| 960 |
DRUG EXPOSURE DURING PREGNANCY |
5 |
0.0001 |
| 961 |
MEMORY IMPAIRMENT |
20 |
0.0001 |
| 962 |
MYOCARDIAL INFARCTION |
25 |
0.0001 |
| 963 |
ASTHMA |
16 |
0.0001 |
| 964 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
10 |
0.0001 |
| 965 |
EYE IRRITATION |
8 |
0.0001 |
| 966 |
PRODUCT SUBSTITUTION ISSUE |
8 |
0.0001 |
| 967 |
FEELING ABNORMAL |
33 |
0.0001 |
| 968 |
CRYING |
5 |
0.0001 |
| 969 |
ANGIOEDEMA |
6 |
0.0001 |
| 970 |
CARDIAC DISORDER |
12 |
0.0001 |
| 971 |
INTENTIONAL PRODUCT MISUSE |
11 |
0.0001 |
| 972 |
MOBILITY DECREASED |
9 |
0.0001 |
| 973 |
DYSKINESIA |
5 |
0.0001 |
| 974 |
HOT FLUSH |
9 |
0.0001 |
| 975 |
INCORRECT DOSE ADMINISTERED |
27 |
0.0001 |
| 976 |
BLOOD GLUCOSE INCREASED |
22 |
0.0001 |
| 977 |
MIGRAINE |
10 |
0.0001 |
| 978 |
PRODUCT STORAGE ERROR |
9 |
0.0001 |
| 979 |
OVERDOSE |
22 |
0.0001 |
| 980 |
INJURY |
7 |
0.0001 |
| 981 |
NO ADVERSE EVENT |
18 |
0.0001 |
| 982 |
SUICIDE ATTEMPT |
6 |
0.0001 |
| 983 |
SUICIDAL IDEATION |
9 |
0.0001 |
| 984 |
DERMATITIS ATOPIC |
5 |
0.0001 |
| 985 |
ALOPECIA |
18 |
0.0001 |
| 986 |
FLUSHING |
8 |
0.0001 |
| 987 |
INJECTION SITE HAEMORRHAGE |
6 |
0.0001 |
| 988 |
INJECTION SITE PRURITUS |
5 |
0.0001 |
| 989 |
MUSCULOSKELETAL STIFFNESS |
6 |
0.0001 |
| 990 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
13 |
0.0001 |
| 991 |
INJECTION SITE ERYTHEMA |
7 |
0.0001 |
| 992 |
INJECTION SITE PAIN |
17 |
0.0001 |
| 993 |
RHEUMATOID ARTHRITIS |
6 |
0.0001 |